Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET/CT: SUVmax versus total lung glycolysis

BACKGROUND: (18)F-FDG PET/CT has proven to be a reliable tool for therapy monitoring in sarcoidosis. Previous PET studies investigated the SUVmax as a marker for disease activity. Total lung glycolysis (TLuG) is a new tool, quantifying the glycolysis of the entire lung. Since SUVmax represents the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Schimmelpennink, Milou C., Vorselaars, Adriane D. M., Veltkamp, Marcel, Keijsers, Ruth G. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565791/
https://www.ncbi.nlm.nih.gov/pubmed/31197630
http://dx.doi.org/10.1186/s13550-019-0505-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6565791/
https://www.ncbi.nlm.nih.gov/pubmed/31197630
http://dx.doi.org/10.1186/s13550-019-0505-x

Ejemplares similares